Seres Therapeutics CFO Marella Thorell resigns, effective November 15, 2026

MCRB•2026-10-26

Seres Therapeutics said CFO and Executive Vice President Marella Thorell will resign effective November 15, 2026, and is expected to provide advisory services afterward.

1. CFO departure

Seres Therapeutics said Marella Thorell will resign as executive vice president and CFO effective November 15, 2026. The company expects her to provide advisory services after that date.

Sources

Seres Therapeutics CFO Marella Thorell resigns, effective November 15, 2026

Sec

Seres Therapeutics CFO Marella Thorell resigns, effective November 15, 2026

1. CFO departure

Related News

West Pharmaceutical Services terminates credit agreement without early termination penalties

North Haven Private Income Fund LLC enters merger agreement with North Haven Private Income Fund A LLC

Freddie Mac total mortgage portfolio increased at an annualized rate of 1.4% in September

Sources

Seres Therapeutics CFO Marella Thorell resigns, effective November 15, 2026

KKR FS Income Trust accepts 874,710 shares in issuer tender offer at $29.13 per share

Commercial National Financial Corporation reports 3rd quarter 2026 results